Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome

DH Roukos, E Briasoulis - Nature Clinical Practice Oncology, 2007 - nature.com
… confer susceptibility to breast and ovarian cancer and to a … to cancer because familial
breast and/or ovarian cancer tend … and patients with hereditary breast ovarian cancer (HBOC) …

[HTML][HTML] Hereditary breast and ovarian cancer susceptibility genes

H Kobayashi, S Ohno, Y Sasaki… - Oncology …, 2013 - spandidos-publications.com
cancer prone syndromes (2–7). Patients predisposed to breast and ovarian cancers are
known as the hereditary … impact on the management of hereditary breast and ovarian cancers. …

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breastovarian cancer

MJ Hall, JE Reid, LA Burbidge, D Pruss… - Cancer, 2009 - Wiley Online Library
… In women at increased risk for breast and ovarian cancer, the identification of a mutation
in breast cancer gene 1 (BRCA1) and BRCA2 has important implications for screening and …

[HTML][HTML] Pathology of hereditary breast and ovarian cancer

A Hodgson, G Turashvili - Frontiers in Oncology, 2020 - frontiersin.org
… risk for either breast or tubo-ovarian cancer with minimal to … risk of breast cancer without
risk of tubo-ovarian cancer, and … have an increased risk for tubo-ovarian cancer, while there is …

Hereditary breast and ovarian cancer: review and future perspectives

MP Lux, PA Fasching, MW Beckmann - Journal of molecular medicine, 2006 - Springer
Breast cancer (BC) is the most frequent carcinoma in women. The cumulative risk for the
disease is 10% up to the age of 80 years. A familial history of BC and ovarian cancer (OC) is a …

[HTML][HTML] BRCA1-and BRCA2-associated hereditary breast and ovarian cancer

N Petrucelli, MB Daly, T Pal - 2022 - europepmc.org
… -associated hereditary breast and ovarian cancer (HBOC) is … breast cancer, ovarian cancer
(including fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers

Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist

HT Lynch, CL Snyder, JF Lynch, BD Riley… - Journal of clinical …, 2003 - ascopubs.org
… managing patients at high risk for hereditary breast cancer. Design: We have studied 98
extended hereditary breast cancer (HBC)/hereditary breast-ovarian cancer (HBOC) families with …

Management of hereditary breast and ovarian cancer

H Yamauchi, J Takei - International journal of clinical oncology, 2018 - Springer
… In case of mutations in the BRCA2 gene, the cumulative risk of breast cancer up to the age
70 years is 84% [2]. The risk of ovarian cancer with pathogenic mutations in BRCA1 is 63% by …

[HTML][HTML] Hereditary breast and ovarian cancer: new genes, new treatments, new concepts

A Meindl, N Ditsch, K Kast, K Rhiem… - Deutsches Ärzteblatt …, 2011 - ncbi.nlm.nih.gov
Hereditary breast and ovarian cancers are caused by an autosomal dominant inheritance
with incomplete penetrance. Population-based studies put its penetrance for breast cancer at …

Hereditary breast and ovarian cancer: new genes in confined pathways

FC Nielsen, T van Overeem Hansen… - … Reviews Cancer, 2016 - nature.com
Genetic abnormalities in the DNA repair genes BRCA1 and BRCA2 predispose to hereditary
breast and ovarian cancer (HBOC). However, only approximately 25% of cases of HBOC …